Skip to main content

Man Group plc

SEC CIK
0001637460
Latest filing
Aug 14, 2026

ABCL holding history

AbCellera Biologics Inc. in every 13F filed by Man Group plc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABCL overviewAll 13F holders of ABCLFull Q2 2026 holdings

Shares (Q2 2026)
228,979
Value
$1.80M
% of portfolio
<0.1%
Quarters held
8
Since Q1 2021
Holdings of ABCL by Man Group plc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026228,979$1.80M<0.1%+228,979NewHolders
Q2 20240$00.0%−771,934−100.0%Sold outHolders
Q1 2024771,934$3.50M<0.1%+771,934NewHolders
Q1 20230$00.0%−305,478−100.0%Sold outHolders
Q4 2022305,478$3.09M<0.1%−359,944−54.1%ReducedHolders
Q3 2022665,422$6.58M<0.1%––Holders
Q2 2022–$2.04M<0.1%–NewHolders
Q4 20210$00.0%−49,165−100.0%Sold outHolders
Q3 202149,165$985.0K<0.1%+3,308+7.2%AddedHolders
Q2 202145,857$1.01M<0.1%+552+1.2%AddedHolders
Q1 202145,305$1.54M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.